Futibatinib
CAS: 1448169-71-8
Indication: For the treatment of cholangiocarcinoma (bile duct cancer).
CAS: 1448169-71-8
Indication: For the treatment of cholangiocarcinoma (bile duct cancer).
Address: RM503, Wanhai Building B, Nanhai Avenue, Nanshan District,Shenzhen 518067 P.R. China.
Tel: (86) 755-82960263 (For All)
Web: www.haorui.com
Email: info@haorui.com
